Charles Gayer
Corporate Officer/Principal en BIOCRYST PHARMACEUTICALS, INC. .
Fortuna: 1 M $ al 31/03/2024
Perfil
Charles K.
Gayer is currently the Chief Commercial Officer at BioCryst Pharmaceuticals, Inc. He started this position in 2020.
Prior to his current role, he obtained an undergraduate degree from Princeton University and an MBA from The Fuqua School of Business.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 19/12/2023 | 274 533 ( 0.13% ) | 1 M $ | 31/03/2024 |
Cargos activos de Charles Gayer
| Empresas | Cargo | Inicio |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/08/2015 |
Formación de Charles Gayer.
| Princeton University | Undergraduate Degree |
| The Fuqua School of Business | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
- Bolsa de valores
- Insiders
- Charles Gayer
